Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

Similar articles for PubMed (Select 24636295)

1.

[Diagnostic value of absent ductular reaction at hepatocellular-stromal boundaries in early stage hepatocellular carcinoma].

Zhang Q, Ma Z, Xin Q, Liu GQ, Liu BB, Gao YT, Zhang CS, Du Z.

Zhonghua Gan Zang Bing Za Zhi. 2013 Dec;21(12):924-8. doi: 10.3760/cma.j.issn.1007-3418.2013.12.010. Chinese.

PMID:
24636295
2.

Perinodular ductular reaction/epithelial cell adhesion molecule loss in small hepatic nodules.

Zhang Q, Zhang CS, Xin Q, Ma Z, Liu GQ, Liu BB, Wang FM, Gao YT, Du Z.

World J Gastroenterol. 2014 Aug 21;20(31):10908-15. doi: 10.3748/wjg.v20.i31.10908.

3.

Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules.

Park YN, Kojiro M, Di Tommaso L, Dhillon AP, Kondo F, Nakano M, Sakamoto M, Theise ND, Roncalli M.

Cancer. 2007 Mar 1;109(5):915-23.

4.

Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence.

Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H, Tanaka S, Kaneda K, Hirohashi K.

Cancer Sci. 2003 Oct;94(10):851-7.

PMID:
14556657
5.

The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.

Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, Lesaffre E, Libbrecht L, Desmet V, Roskams T.

Histopathology. 2006 Aug;49(2):138-51.

PMID:
16879391
6.

[CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].

Wang ZS, Wu LQ, Yi X, Geng C, Li YJ, Yao RY, Hu WY, Han B.

Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):753-8. doi: 10.3760/cma.j.issn.0253-3766.2012.10.008. Chinese.

PMID:
23291069
7.

Expression of contactin associated protein-like 2 in a subset of hepatic progenitor cell compartment identified by gene expression profiling in hepatitis B virus-positive cirrhosis.

Wang H, Gao Y, Jin X, Xiao J.

Liver Int. 2010 Jan;30(1):126-38. doi: 10.1111/j.1478-3231.2009.02151.x. Epub 2009 Nov 4.

PMID:
19889080
8.

Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma.

Xu M, Xie F, Qian G, Jing Y, Zhang S, Gao L, Zheng T, Wu M, Yang J, Wei L.

BMC Cancer. 2014 Feb 5;14:65. doi: 10.1186/1471-2407-14-65.

9.

Comparative analysis of immunohistochemical markers for differential diagnosis of hepatocelluar carcinoma and cholangiocarcinoma.

Ryu HS, Lee K, Shin E, Kim SH, Jing J, Jung HY, Lee H, Jang JJ.

Tumori. 2012 Jul-Aug;98(4):478-84. doi: 10.1700/1146.12643.

PMID:
23052165
10.

Morphometric and immunohistochemical study of cholangiolocellular carcinoma: comparison with non-neoplastic cholangiole, interlobular duct and septal duct.

Maeno S, Kondo F, Sano K, Takada T, Asano T.

J Hepatobiliary Pancreat Sci. 2012 May;19(3):289-96. doi: 10.1007/s00534-011-0483-5.

11.

Hepatocellular dysplastic nodules.

Roncalli M, Borzio M, Di Tommaso L.

Ann Ital Chir. 2008 Mar-Apr;79(2):81-9.

PMID:
18727269
12.

Primary liver carcinoma arising in people younger than 30 years.

Klein WM, Molmenti EP, Colombani PM, Grover DS, Schwarz KB, Boitnott J, Torbenson MS.

Am J Clin Pathol. 2005 Oct;124(4):512-8.

13.

Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.

Shirakawa H, Kuronuma T, Nishimura Y, Hasebe T, Nakano M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, Kinoshita T, Nakatsura T.

Int J Oncol. 2009 Mar;34(3):649-56.

PMID:
19212669
14.

Immunohistochemical characteristics of hepatocellular carcinoma in non-cirrhotic livers.

Witjes CD, ten Kate FJ, Verhoef C, de Man RA, IJzermans JN.

J Clin Pathol. 2013 Aug;66(8):687-91. doi: 10.1136/jclinpath-2012-201156. Epub 2013 Apr 12.

PMID:
23585667
15.

Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.

Zhang F, Chen XP, Zhang W, Dong HH, Xiang S, Zhang WG, Zhang BX.

Histopathology. 2008 Jan;52(2):224-32. doi: 10.1111/j.1365-2559.2007.02929.x.

PMID:
18184271
16.

Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.

Shibuya M, Kondo F, Sano K, Takada T, Asano T.

J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):537-43. doi: 10.1007/s00534-010-0365-2.

PMID:
21234612
17.

Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis.

Kobayashi M, Ikeda K, Hosaka T, Sezaki H, Someya T, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Kumada H.

Cancer. 2006 Feb 1;106(3):636-47.

18.

Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.

Kwon Y, Lee SK, Kim JS, Ro JY, Yu E.

Mod Pathol. 2002 Oct;15(10):1096-101.

20.

Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.

Sempoux C, Fan C, Singh P, Obeidat K, Roayaie S, Schwartz M, Fiel MI, Thung SN.

Semin Liver Dis. 2011 Feb;31(1):104-10. doi: 10.1055/s-0031-1272838. Epub 2011 Feb 22.

PMID:
21344355
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk